Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  American Journal of Tropical Medicine and Hygiene

• Publication date

  1992-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4269/AJTMH.1992.46.296PMID 1313656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.

  1992cited by this paper
• Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate.

  1991cited by this paper
• Efficacy and toxicity of pentostam against Panamanian mucosal leishmaniasis.

  1991cited by this paper
• Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis.

  1990cited by this paper
• Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.

  1990cited by this paper
• Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate.

  1990cited by this paper
• Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis.

  1990cited by this paper
• Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.

  1989cited by this paper
• Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies.

  1988cited by this paper
• Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study

  1988cited by this paper
• Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis.

  1987cited by this paper
• Harmful effect of high stibogluconate treatment of kala-azar in India.

  1986cited by this paper
• Mucosal leishmaniasis ("espundia" Escomel, 1911).

  1986cited by this paper
• Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate).

  1985cited by this paper
• Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.

  1984cited by this paper
• The response of Kenyan kala-azar to treatment with sodium stibogluconate.

  1984cited by this paper
• A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya.

  1983cited by this paper
• Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya.

  1983cited by this paper
• Renal clearance of pentavalent antimony (sodium stibogluconate).

  1980cited by this paper

• Chemotherapy Resistance Status of Common Human Pathogenic Protozoa

  2025cites this paper
• Leishmaniose

  2025cites this paper
• Advances in Cysteine Protease B Inhibitors for Leishmaniasis Treatment.

  2024cites this paper
• Improved Topical Delivery of Sorafenib-Meglumine Antimoniate: Elastic Nano-Liposomal Formulation for the Treatment of Cutaneous Leishmaniasis

  2024cites this paper
• Molecular Mechanisms of Drug Resistance in Leishmania spp.

  2024cites this paper
• Tri-aryl antimony(V) hydroximato and hydroxamato complexes: Combining lipophilic Sb(III/V) and hydroxamic acids in combating Leishmania.

  2024cites this paper
• Vaccine Designing Technology against Leishmaniasis: Current Challenges and Implication.

  2024cites this paper
• Chemistry of Antimony in Radiopharmaceutical Development: Unlocking the Theranostic Potential of Sb Isotopes

  2024cites this paper
• A review on cardiac manifestation of parasitic infection

  2023cites this paper
• Development of a microemulsion loaded with epoxy-α-lapachone against Leishmania (Leishmania) amazonensis murine infection.

  2023cites this paper
• Drug-Induced Acute Pancreatitis in Adults: Focus on Antimicrobial and Antiviral Drugs, a Narrative Review

  2023cites this paper
• Intralesional Meglumine Antimoniate: Safe, Feasible and Effective Therapy for Cutaneous Leishmaniasis in Bolivia

  2022cites this paper
• Biochemical And Heamatological Evaluation Pattern Of Pentostam- Induced Hepatotoxicity And Nephrotoxicity In Albino Mice

  2022cites this paper
• Efficacy of Systemic Treatment for Leishmania tropica Cutaneous Leishmaniasis

  2022cites this paper
• Involvement of Leishmania Phosphatases in Parasite Biology and Pathogeny

  2021cites this paper
• Potential of Piper spp. as a source of new compounds for the leishmaniases treatment

  2021cites this paper
• Assessment of serum amylase, lipase and associated factors among patients with visceral leishmaniasis treated with sodium stibogluconate/paromomycin at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

  2021cites this paper
• Evaluation of cytochrome b sequence to identify Leishmania species and variants: the case of Panama

  2021cites this paper
• Synthesis, Structural Characterization, and Optical Properties of Benzene-Fused Tetracyclic and Pentacyclic Stiboles

  2021cites this paper
• The thiol-based reduction of Bi(V) and Sb(V) anti-leishmanial complexes.

  2021cites this paper
• A Review on Cutaneous Leishmaniasis

  2021cites this paper
• Stage-Specific Class I Nucleases of Leishmania Play Important Roles in Parasite Infection and Survival

  2021cites this paper
• Improving the miltefosine efficacy against leishmaniasis by using different nanoassemblies made from surfactants or amphiphilic antimony (V) complex

  2021cites this paper
• Elucidation of the interaction between human serum albumin (HSA) and 3,4-methylenedioxyde-6-iodo-benzaldehyde-thiosemicarbazone, a potential drug for Leishmania amazonensis: Multiple spectroscopic and dynamics simulation approach

  2020cites this paper
• Visceral leishmaniasis in Saudi Arabia: from hundreds of cases to zero.

  2020cites this paper
• Nanotechnology in Skin, Soft Tissue, and Bone Infections

  2020cites this paper
• Nanobiotechnological Strategies for Treatment of Tegumentary and Visceral Leishmaniasis Including Resistance Strains

  2020cites this paper
• Treatment of Cutaneous Leishmaniasis with Photodynamic Therapy: The First Case Report from Khyber Pakhthunkhwa (KPK), Swat Pakistan

  2020cites this paper
• Helmholtz-Zentrum Dresden-Rossendorf (HZDR) In situ Structural Study of Sb(V) Adsorption on Hematite (1-102) Using X-ray Surface Scattering

  2020cites this paper
• Pentavalent Antimony

  2020cites this paper
• Anti-leishmanial activity and cytotoxicity of a series of tris-aryl Sb(V) mandelate cyclometallate complexes.

  2019cites this paper
• Identification of Phenylphthalazinones as a New Class of Leishmania infantum Inhibitors

  2019cites this paper
• The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis

  2019cites this paper
• The effect of calcination temperature and solvent on the synthesis of CuO nanoparticles and assessment as an anti-leishmania agent

  2019cites this paper
• Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis

  2019cites this paper
• Evaluation of the Effect of Achillea biebersteinii afan Essential Oil on Leishmania major Promastigote and Amastigote Growth under In Vitro Conditions

  2019cites this paper
• Leishmaniasis

  2019cites this paper
• Visseral Leishmaniasis (Kala Azar) tedavisinde allopurinol ve ketakonazol kullanımı

  2019cites this paper
• Embryonic toxico-pathological effects of meglumine antimoniate using a chick embryo model

  2018cites this paper
• Treatment of tegumentary forms of leishmaniasis

  2018cites this paper
• Fcγ‐RI, Fcγ‐RII and IL‐10 as predictive biomarkers for post‐therapeutic cicatrization time in monocytes from cutaneous leishmaniasis patients

  2018cites this paper
• In Situ Structural Study of Sb(V) Adsorption on Hematite (11̅02) Using X-ray Surface Scattering.

  2018cites this paper
• Evidence for Tissue Toxicity in BALB/c Exposed to a Long-Term Treatment with Oxiranes Compared to Meglumine Antimoniate

  2017cites this paper
• METHODS USEFUL IN MODULATING PROTEIN TYROSINE PHOSPHATASES

  2017cites this paper
• 157 – Antiparasitic Agents

  2017cites this paper
• Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites

  2017cites this paper
• Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.

  2017cites this paper
• Application of nanotechnology in treatment of leishmaniasis: A Review.

  2017cites this paper
• Structure and binding studies of proliferating cell nuclear antigen from Leishmania donovani.

  2017cites this paper
• Natural products and phytotherapy: an innovative perspective in leishmaniasis treatment

  2017cites this paper
• Nanoarchitectures for Neglected Tropical Protozoal Diseases: Challenges and State of the Art

  2017cites this paper
• Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)*

  2017cites this paper
• Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil

  2017cites this paper
• Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia

  2016cites this paper
• Got the Travel Bug? A Review of Common Infections, Infestations, Bites, and Stings Among Returning Travelers

  2016cites this paper
• Mucocutaneous and visceral leishmaniasis in renal transplant patient from nonendemic region.

  2016cites this paper
• Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

  2016cites this paper
• Clinical audit: Baseline investigations for intramuscular meglumine antimoniate in cases of cutaneous leishmaniasis

  2016cites this paper
• Eficacia de anfotericina B y rifampicina en el tratamiento de la leishmaniasis cutánea: Metanálisis

  2016cites this paper
• Electrophoretic separation techniques and their hyphenation to mass spectrometry in biological inorganic chemistry

  2016cites this paper
• Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system.

  2016cites this paper
• Antimony and Nickel

  2016cites this paper
• An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis

  2016cites this paper
• Leishmaniasis

  2016cites this paper
• Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

  2016cites this paper
• Is slit-skin smear an alternate to histopathology in the diagnosis of cutaneous leishmaniasis?

  2016cites this paper
• Design, synthesis, and evaluation of inhibitors of trypanosome growth for neglected disease drug discovery

  2015cites this paper
• Epidemiological studies on zoonotic leishmaniasis and new trials for studying the effect of melatonin on the parasite

  2015cites this paper
• Miltefosine, an FDA-approved drug for the ‘orphan disease’, leishmaniasis

  2015cites this paper
• Antileishmanial drug discovery: comprehensive review of the last 10 years

  2015cites this paper
• Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management.

  2015cites this paper
• Treatment of leishmaniasis: a review and assessment of recent research.

  2015cites this paper
• New World and Old World Leishmania Infections: A Practical Review.

  2015cites this paper
• Evaluation of CO2 laser efficacy in the treatment of cutaneous leishmaniasis in a group of 10 Sudanese patients

  2015cites this paper
• Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide

  2014cites this paper
• Leishmania tropica in children: a retrospective study.

  2014cites this paper
• Double-walled microspheres loaded with meglumine antimoniate: preparation, characterization and in vitro release study

  2014cites this paper
• donovani Leishmania Established and Chronic Stearylamine-Bearing Liposomes against Antimony Gluconate in Combination Therapy Using Sodium

  2014cites this paper
• LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.

  2014cites this paper
• Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis

  2014cites this paper
• Cytotoxic Effects of 5-Fluorouracil on Major Promastigotes and Induction of Apoptosis

  2014cites this paper
• Leishmaniasis mucocutánea en un paciente con infección por VIH: Case report

  2014cites this paper
• New insights into the diagnosis and chemotheraphy for visceral leishmaniasis.

  2014cites this paper
• Proteinase inhibitors: a promising drug class for treating leishmaniasis.

  2014cites this paper
• [Mucocutaneous leishmaniasis in a HIV infected patient. Case report].

  2014cites this paper
• Infections of the Eyelids

  2014cites this paper
• Organotin(IV) complexes of carboxylate derivative as potential chemotherapeutic agents against Leishmania

  2014cites this paper
• An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis

  2014cites this paper
• Stearylamine-Bearing Liposomes Antileishmanial Activities of

  2014cites this paper
• Leishmaniasis in travelers: a literature review.

  2014cites this paper
• Leishmanioses do continente americano

  2014influential citation
• Organotin(IV) carboxylate derivatives as a new addition to anticancer and antileishmanial agents: design, physicochemical characterization and interaction with Salmon sperm DNA

  2014cites this paper
• Natural product based leads to fight against leishmaniasis.

  2014cites this paper
• Uso de terapia fotodinâmica com ftalocianina cloro alumínio no tratamento tópico da leishmaniose cutânea

  2013cites this paper
• Oportunidades para inovação no tratamento da leishmaniose usando o potencial das plantas e produtos naturais como fontes de novos fármacos Potential for innovation in the treatment of leishmaniasis using plants and natural products as sources of new drugs

  2013cites this paper
• Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison

  2013cites this paper
• New world cutaneous leishmaniasis: obstacles in initiating treatment with sodium stibogluconate in 2 travelers from Texas.

  2013cites this paper
• ELECTROCARDIOGRAPHIC CHANGES DURING TREATMENT WITH CUTANEOUS LEISHMANIASIS

  2013cites this paper
• Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

  2013cites this paper
• Public health aspects of visceral leishmaniasis in Montenegro

  2013cites this paper